Eurofins Scientific SE Share Price
Stocks
ERF
FR0014000MR3
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Euronext Paris
16:55:00 25/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 74.08 EUR | +1.12% |
|
+6.35% | +18.72% |
| 08-24 | Wall Street's Three-Way Stress Test | |
| 07-23 | Eurofins Scientific SE, H1 2026 Earnings Call, Jul 23, 2026 |
| Market Cap | 12.86B 15.01B 12.05B 11.01B 20.77B 1,431B 20.98B 142B 55.33B 722B 56.35B 55.12B 2,391B | P/E 2026 * |
24.7x | P/E 2027 * | 19.5x |
|---|---|---|---|---|---|
| Enterprise Value | 16.21B 18.92B 15.19B 13.87B 26.18B 1,803B 26.44B 179B 69.74B 910B 71.03B 69.48B 3,013B | EV / Sales 2026 * |
2.14x | EV / Sales 2027 * | 1.98x |
| Free-Float |
60.39% | Yield 2026 * |
1.09% | Yield 2027 * | 1.24% |
Last Transcript: Eurofins Scientific SE
| 1 day | +1.12% | ||
| 1 week | +6.35% | ||
| Current month | +8.69% | ||
| 1 month | +11.57% | ||
| 3 months | +17.14% | ||
| 6 months | +10.24% | ||
| Current year | +18.72% |
| 1 week | 70.5 | 74.32 | |
| 1 month | 66.4 | 74.32 | |
| Current year | 56.84 | 74.32 | |
| 1 year | 54.86 | 74.32 | |
| 3 years | 39.47 | 74.32 | |
| 5 years | 39.47 | 127.68 | |
| 10 years | 29.82 | 127.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CEO | Chief Executive Officer | 63 | 31/12/1986 |
Laurent Lebras
DFI | Director of Finance/CFO | - | 31/12/2014 |
Christian Wurst
PRN | Corporate Officer/Principal | 54 | 30/09/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Martin
CHM | Chairman | 63 | 31/12/1986 |
Yves-Loïc Martin
BRD | Director/Board Member | 60 | 31/12/2014 |
Valérie Hanote
BRD | Director/Board Member | 60 | 31/12/1989 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 27/02/26 | Buy | Chief Executive Officer | 1,000 | 0.0005% | ||
| 27/02/26 | Buy | Chief Executive Officer | 1,000 | 0.0005% | ||
| 27/02/26 | Buy | Chief Executive Officer | 1,000 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.12% | +6.35% | +11.00% | +32.62% | 14.84B | ||
| +1.02% | +4.95% | +3.67% | +25.46% | 51.21B | ||
| -0.09% | -2.14% | +492.60% | +537.84% | 45.35B | ||
| -0.32% | +8.08% | +37.97% | +18.45% | 42.84B | ||
| +1.18% | +1.96% | +21.95% | +89.69% | 42.29B | ||
| -2.27% | -3.02% | +14.22% | +51.50% | 32.15B | ||
| -0.96% | +4.03% | +31.55% | +136.34% | 17.31B | ||
| +0.41% | +1.66% | - | - | 16.55B | ||
| -0.31% | +6.61% | +81.37% | +48.53% | 14.25B | ||
| -2.63% | +1.11% | -1.65% | -34.10% | 13.38B | ||
| Average | -0.30% | +2.86% | +76.96% | +100.70% | 29.02B | |
| Weighted average by Cap. | -0.10% | +2.77% | +100.08% | +127.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.59B 8.86B 7.11B 6.49B 12.26B 844B 12.38B 83.87B 32.65B 426B 33.25B 32.53B 1,411B | 8.01B 9.35B 7.51B 6.86B 12.94B 891B 13.07B 88.53B 34.46B 450B 35.1B 34.33B 1,489B |
| Net income | 531M 620M 497M 454M 858M 59.07B 866M 5.87B 2.28B 29.8B 2.33B 2.28B 98.69B | 660M 770M 618M 565M 1.07B 73.39B 1.08B 7.29B 2.84B 37.03B 2.89B 2.83B 123B |
| Net Debt | 3.35B 3.91B 3.14B 2.87B 5.41B 373B 5.46B 37.02B 14.41B 188B 14.68B 14.36B 623B | 3.01B 3.52B 2.82B 2.58B 4.87B 335B 4.92B 33.31B 12.97B 169B 13.21B 12.92B 560B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/08/26 | €74.08 | +1.12% | 133,674 |
| 24/08/26 | €73.26 | +0.58% | 140,808 |
| 21/08/26 | €72.84 | +0.03% | 210,856 |
| 20/08/26 | €72.82 | +3.06% | 323,338 |
| 19/08/26 | €70.66 | +1.44% | 210,639 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ERF Stock
Select your edition
All financial news and data tailored to specific country editions



















